retatrutide trial data This from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Michael Weintraub, MD on X:

While GLP-1 agonist therapy medications have been marketed as diabetes treatments before, Mounjaro also has the action of glucose-dependent insulinotropic polypeptide (GIP)

Hyperbranched cationic glycogen derivative-mediated IB gene silencing regulates the uveoscleral outflow pathway in rats

Mounjaro revenue saw a 109% increase in revenue from the third quarter Eli Lilly is on track to overtake pharma rivals and claim the industrys top spot by late 2026, completing one of the most dramatic repositionings in Big Pharmas recent history

If you experience severe right-upper-abdominal pain or jaundice, seek medical evaluation

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2